General Mills (NYSE:GIS) PT Raised to $96.00 at UBS Group
General Mills (NYSE:GIS) PT Raised to $96.00 from $88.00 at UBS Group
General Mills (NYSE:GIS) PT Raised to $96.00 at UBS Group Read Post »
UBS
UBS Adjusts United States Steel (NYSE:X) Price Target to $27 From $25
UBS Adjusts United States Steel (NYSE:X) Price Target to $27 From $25, Maintains Neutral Rating.
UBS Adjusts United States Steel (NYSE:X) Price Target to $27 From $25 Read Post »
UBS Adjusts Nucor (NYSE:NUE) Price Target to $150 From $140
UBS Adjusts Nucor (NYSE:NUE) Price Target to $150 From $140, Maintains Neutral Rating.
UBS Adjusts Nucor (NYSE:NUE) Price Target to $150 From $140 Read Post »
UBS Adjusts NVIDIA (NASDAQ:NVDA) Price Target to $315 From $270
UBS analyst Timothy Arcuri maintains NVIDIA (NASDAQ:NVDA) with a Buy and raises the price target from $270 to $315.
UBS Adjusts NVIDIA (NASDAQ:NVDA) Price Target to $315 From $270 Read Post »
UBS Adjusts Oracle (NYSE:ORCL) Price Target to $90 From $87
UBS Adjusts Oracle (NYSE:ORCL) Price Target to $90 From $87, Maintains Neutral Rating.
UBS Adjusts Oracle (NYSE:ORCL) Price Target to $90 From $87 Read Post »
UBS Initiates Coverage On Intuit (NASDAQ:INTU) With Neutral Rating, Announces Price Target of $430
UBS analyst Taylor McGinnis initiates coverage on Intuit (NASDAQ:INTU) with a Neutral rating and announces Price Target of $430.
Microsoft (NASDAQ:MSFT) price target Set at $275.00 by UBS Group
Microsoft (NASDAQ:MSFT) price target Set at $275.00 by UBS Group
Microsoft (NASDAQ:MSFT) price target Set at $275.00 by UBS Group Read Post »
UBS Adjusts Price Target on Caterpillar (NYSE:CAT) to $210 From $225
UBS Adjusts Price Target on Caterpillar (NYSE:CAT) to $210 From $225, Maintains Sell Rating.
UBS Adjusts Price Target on Caterpillar (NYSE:CAT) to $210 From $225 Read Post »
UBS Group Reiterates $45.00 Price Target for Pfizer (NYSE:PFE)
UBS Group Reiterates $45.00 Price Target for Pfizer (NYSE:PFE)
UBS Group Reiterates $45.00 Price Target for Pfizer (NYSE:PFE) Read Post »
UBS: reiterated Meta Platforms (NASDAQ:META) Buy Rating with a $235 price target
UBS reiterated its Buy rating on Meta Platforms (NASDAQ:META) with a price target of $235 and continued to rank the stock as the “best option,” with a $3 billion operating cost cut combined with a $3 billion restructuring charge to reduce core operating costs by $6 billion in 2023 and approximately $8 billion in operating cost savings in 2024. UBS said this equates to nearly $2.50 in tax-affected earnings per share, while the bank’s forecast for GAAP earnings per share for fiscal 2024 ($13) is higher than consensus expectations.
UBS: reiterated Meta Platforms (NASDAQ:META) Buy Rating with a $235 price target Read Post »
UBS Adjusts Teladoc Health(NYSE:TDOC) Price Target to $29 From $32
UBS Adjusts Teladoc Health(NYSE:TDOC) Price Target to $29 From $32, Maintains Neutral Rating.
UBS Adjusts Teladoc Health(NYSE:TDOC) Price Target to $29 From $32 Read Post »
UBS upgraded Procter & Gamble (NYSE:PG) to “buy” with a price target of $163
UBS upgraded Procter & Gamble (NYSE:PG) to “buy” with a price target of $163。
UBS upgraded Procter & Gamble (NYSE:PG) to “buy” with a price target of $163 Read Post »